1
Deprest J, Ghidini A, Van Mieghem T, et al. In case you missed it: the editors bring you the most significant advances of 2015. Prenatal Diagnosis 2016;36:3–9. doi:10.1002/pd.4758
2
Smith NC, Smith APM, Smith NC. Obstetric and gynaecological ultrasound made easy. 2nd ed. Edinburgh: : Elsevier Churchill Livingstone 2006.
3
Pandya PP, Wapner R, Oepkes D, et al., editors. Fetal medicine: basic science and clinical practice. Third edition. [London?]: : Elsevier 2020. https://www.sciencedirect.com/science/book/9780702069567
4
Sadler TW. Langman’s medical embryology. Thirteenth edition, International edition. Philadelphia: : Wolters Kluwer 2015.
5
Baillière’s Clinical Obstetrics and Gynaecology. 1987;1.http://www.sciencedirect.com/science/journal/09503552/1/3
6
Milunsky A, Milunsky JM, editors. Genetic Disorders and the Fetus. Oxford, UK: : John Wiley & Sons Ltd. 2021. doi:10.1002/9781119676980
7
Simpson JL, Elias S. Essentials of prenatal diagnosis. New York: : Churchill Livingstone 1993.
8
Harrison MR, Golbus MS, Filly RA, et al. The unborn patient: the art and science of fetal therapy. 3rd ed. Philadelphia: : Saunders 2001.
9
Chudleigh P, Thilaganathan B. Obstetric ultrasound: how, why and when. 3rd ed. Edinburgh: : Elsevier Churchill Livingstone 2004.
10
Abramsky L, Chapple J. Prenatal diagnosis: the human side. 2nd ed. Cheltenham, U.K.: : Nelson Thornes 2003.
11
International Society for Prenatal Diagnosis. Prenatal diagnosis. ;Wiley medical publication.http://onlinelibrary.wiley.com/journal/10.1002/%28ISSN%291097-0223/issues
12
International Fetal Medicine and Surgery Society. Fetal diagnosis and therapy. http://www.karger.com/Journal/Home/224239
13
European Society of Human Genetics. European journal of human genetics: EJHG. http://www.nature.com/ejhg/archive/index.html
14
Journal of Prenatal Medicine. https://www.degruyter.com/journal/key/jpme/html?lang=en
15
PloS one. https://journals.plos.org/plosone/
16
American Association for Clinical Chemistry. Clinical chemistry. http://www.clinchem.org/content/by/year
17
Journal of Medical Ethics. Published Online First: 1975.http://www.jstor.org/journal/jmedethics
18
Massachusetts Medical Society. The New England journal of medicine. http://www.nejm.org/medical-index
19
Wald NJ, Bestwick JP. Performance of antenatal reflex DNA screening for Down’s syndrome. Journal of Medical Screening 2015;22:168–74. doi:10.1177/0969141315581005
20
nipd_june_2016.pdf. http://www.labs.gosh.nhs.uk/media/764057/nipd_june_2016.pdf
21
Chitty LS, van der Schoot CE, Hahn S, et al. SAFE—TheSpecial Non-invasiveAdvances inFetal and NeonatalEvaluation Network: aims and achievements. Prenatal Diagnosis 2008;28:83–8. doi:10.1002/pd.1929
22
Wright CF, Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Human Reproduction Update 2008;15:139–51. doi:10.1093/humupd/dmn047
23
Hill M, Barrett AN, White H, et al. Uses of cell free fetal DNA in maternal circulation. Best Practice & Research Clinical Obstetrics & Gynaecology 2012;26:639–54. doi:10.1016/j.bpobgyn.2012.03.004
24
Sparks AB, Wang ET, Struble CA, et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenatal Diagnosis 2012;32:3–9. doi:10.1002/pd.2922
25
Barrett AN, McDonnell TCR, Chan KCA, et al. Digital PCR Analysis of Maternal Plasma for Noninvasive Detection of Sickle Cell Anemia. Clinical Chemistry 2012;58:1026–32. doi:10.1373/clinchem.2011.178939
26
Bianchi DW, Platt LD, Goldberg JD, et al. Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing. Obstetrics & Gynecology 2012;119:890–901.http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00006250-201205000-00004&LSLINK=80&D=ovft
27
Ravitsky V. Non-invasive prenatal diagnosis: an ethical imperative. Nature Reviews Genetics 2009;10:733–733. doi:10.1038/nrg2631-c1
28
Benn PA. Practical and Ethical Considerations of Noninvasive Prenatal Diagnosis. JAMA 2009;301. doi:10.1001/jama.2009.707
29
Deans Z, Clarke AJ, Newson AJ. For Your Interest? The Ethical Acceptability of Using Non-Invasive Prenatal Testing to Test ‘Purely for Information’. Bioethics 2015;29:19–25. doi:10.1111/bioe.12125
30
Agathokleous M, Chaveeva P, Poon LCY, et al. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound in Obstetrics & Gynecology 2013;41:247–61. doi:10.1002/uog.12364
31
Celik E, To M, Poon LCY, et al. Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment. Ultrasound in Obstetrics and Gynecology 2008;31:549–54. doi:10.1002/uog.5333
32
Gallo D, Poon LC, Fernandez M, et al. Prediction of Preeclampsia by Mean Arterial Pressure at 11-13 and 20-24 Weeks’ Gestation. Fetal Diagnosis and Therapy 2014;36:28–37. doi:10.1159/000360287
33
Gallo DM, Poon LC, Akolekar R, et al. Prediction of Preeclampsia by Uterine Artery Doppler at 20-24 Weeks’ Gestation. Fetal Diagnosis and Therapy 2013;34:241–7. doi:10.1159/000356171
34
Nicolaides KH. Turning the Pyramid of Prenatal Care. Fetal Diagnosis and Therapy 2011;29:183–96. doi:10.1159/000324320
35
Syngelaki A, Chelemen T, Dagklis T, et al. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenatal Diagnosis 2011;31:90–102. doi:10.1002/pd.2642
36
Syngelaki A, Pergament E, Homfray T, et al. Replacing the Combined Test by Cell-Free DNA Testing in Screening for Trisomies 21, 18 and 13: Impact on the Diagnosis of Other Chromosomal Abnormalities. Fetal Diagnosis and Therapy 2014;35:174–84. doi:10.1159/000358388
37
Alessandra Cacciatore. Obstetric management in Rh alloimmunizated pregnancy. Journal of Prenatal Medicine 2009;3.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279102/
